Goto K - Search Results

1

Histone deacetylase inhibitor for the treatment of hepatocellular carcinoma: Chemoimmunotherapeutic perspective and prospects.

Goto K, Kato N. Goto K, et al. J Hepatol. 2017 Apr;66(4):866-867. doi: 10.1016/j.jhep.2016.11.029. Epub 2017 Jan 9. J Hepatol. 2017. PMID: 28082149 No abstract available.

2

Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study.

Goto K, Annan DA, Morita T, Li W, Muroyama R, Matsubara Y, Ito S, Nakagawa R, Tanoue Y, Jinushi M, Kato N. Goto K, et al. Sci Rep. 2016 Dec 2;6:38407. doi: 10.1038/srep38407. Sci Rep. 2016. PMID: 27910927 Free PMC article.

3

miR-425 regulates inflammatory cytokine production in CD4⁺ T cells via N-Ras upregulation in primary biliary cholangitis.

Nakagawa R, Muroyama R, Saeki C, Goto K, Kaise Y, Koike K, Nakano M, Matsubara Y, Takano K, Ito S, Saruta M, Kato N, Zeniya M. Nakagawa R, et al. Among authors: goto k. J Hepatol. 2017 Jun;66(6):1223-1230. doi: 10.1016/j.jhep.2017.02.002. Epub 2017 Feb 10. J Hepatol. 2017. PMID: 28192189

4

Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cells.

Arai J, Goto K, Stephanou A, Tanoue Y, Ito S, Muroyama R, Matsubara Y, Nakagawa R, Morimoto S, Kaise Y, Lim LA, Yoshida H, Kato N. Arai J, et al. Among authors: goto k. J Gastroenterol Hepatol. 2018 May;33(5):1075-1081. doi: 10.1111/jgh.14029. Epub 2018 Feb 6. J Gastroenterol Hepatol. 2018. PMID: 29055152

5

Goto K, Lin W, Zhang L, Jilg N, Shao RX, Schaefer EA, Zhao H, Fusco DN, Peng LF, Kato N, Chung RT. Goto K, et al. J Hepatol. 2013 Nov;59(5):942-8. doi: 10.1016/j.jhep.2013.06.025. Epub 2013 Jul 2. J Hepatol. 2013. PMID: 23831117 Free PMC article.

6

MICA SNPs and the NKG2D system in virus-induced HCC.

Goto K, Kato N. Goto K, et al. J Gastroenterol. 2015 Mar;50(3):261-72. doi: 10.1007/s00535-014-1000-9. Epub 2014 Oct 1. J Gastroenterol. 2015. PMID: 25270965 Review.

7

The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.

Li W, Goto K, Matsubara Y, Ito S, Muroyama R, Li Q, Kato N. Li W, et al. Among authors: goto k. PLoS One. 2015 May 5;10(5):e0125555. doi: 10.1371/journal.pone.0125555. eCollection 2015. PLoS One. 2015. PMID: 25942596 Free PMC article.

8

Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.

Goto K, Kato N, Chung RT. Goto K, et al. Oncotarget. 2016 Nov 15;7(46):74987-74999. doi: 10.18632/oncotarget.11820. Oncotarget. 2016. PMID: 27602492 Free PMC article.

9

Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10.

Goto K, Arai J, Stephanou A, Kato N. Goto K, et al. Oncotarget. 2018 Apr 10;9(27):18821-18831. doi: 10.18632/oncotarget.24568. eCollection 2018 Apr 10. Oncotarget. 2018. PMID: 29721164 Free PMC article.

10

Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.

Arai J, Goto K, Tanoue Y, Ito S, Muroyama R, Matsubara Y, Nakagawa R, Kaise Y, Lim LA, Yoshida H, Kato N. Arai J, et al. Among authors: goto k. Int J Cancer. 2018 Nov 15;143(10):2575-2583. doi: 10.1002/ijc.31615. Epub 2018 Sep 22. Int J Cancer. 2018. PMID: 29873070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,753 results

Search Page

Filters